Search Results

Therapeutic exploitation of novel mouse models and metabolic interventions in leukemia

Our research program aims to gain a deeper understanding of the pathobiology of and HSTL.To this end, we will use novel mouse models, techniques and…

The Leukemia & Lymphoma Society Welcomes Five Members to Board of Directors

(Rye Brook, NY, July , ) - The Leukemia & Lymphoma Society (LLS) announced five new members to its board of directors effective July , : Leroy M. Ball…

FDA Approves BiTE Therapy for Adults and Children with Leukemia Subtype

Blinatumomab has received full approval from the FDA after data confirmed its safety and efficacy.

Burlington Stores Raises More Than $37M For The Leukemia & Lymphoma Society

(RYE BROOK, N.Y., Dec. , ) – Burlington Stores and The Leukemia & Lymphoma Society (LLS) joined forces for the 17th consecutive year to help save live…

The Leukemia & Lymphoma Society Kicks Off Light The Night Fall Campaign

(Los Angeles, CA July , ) – The Leukemia & Lymphoma Society’s (LLS) California Southland Chapter celebrated its Light The Night® with a event and aw…

Interrogation of glutathione biology in relapsed acute myeloid leukemia stem cells

Acute myeloid leukemia (AML) is a devastating blood cancer. Most AML patients will initially respond to standard therapy; however, for many patients t…

Booklet Updates

Blood Cancer United wants you to have the most information about blood cancer treatment. See below for new treatments that have been FDA approved sin…

Follow-Up Care

Click here for information about care, including what to expect, and late effects of treatment, survivorship clinics, and other resources such as Th…

Harnessing the epigenome to advance the classification and understanding of molecular mechanisms underlying hairy cell leukemia variant patients

Patients with B cell malignancies who do not fall into a distinct pathological disease category pose a challenge for patient care, and patient classif…

Pam

Pam Katten died on September , after a battle with acute myeloid leukemia (AML). Pam was an extraordinary woman, beloved as a mother, daughter, sis…

Enhancing the cytotoxicity of T cells in NRAS; ASXL1-AML through combined inhibition of MEK and HDACs

Acute myeloid leukemia (AML) is a heterogeneous malignant blood cancer. Its treatment outcome is influenced by the mutations. Oncogenic NRAS mutation…

Childhood and Adolescent Blood Cancer Facts and Statistics

Childhood and Adolescent Blood Cancers An estimated , children and adolescents younger than years in the US are living with or in remission fro…

Investigating and targeting the histone acetylation reader protein ENL in acute leukemias

Leukemia often results from aberrant gene expression caused by epigenetic alterations. Previously we discovered a novel histone acetylation reader dom…

Understanding and Overcoming Mechanisms of Immune Evasion after Allogeneic Transplant

Outcomes for patients with acute myelogenous leukemia who relapse after transplantation are dismal. This SCOR brings together an international group o…

Strategic combinations to overcome therapeutic resistance and relapse in acute myeloid leukemia

Acute myeloid leukemia (AML) is the most fatal type of leukemia and has a high rate of relapse following current therapies. We have recently uncovered…

The Leukemia & Lymphoma Society Receives $17 Million from the Mike and Sofia Segal Family Foundation to Accelerate Progress in the Treatment of Chronic Myelomonocytic Leukemia

Mike and Sofia Segal, who immigrated to the U.S. from Ukraine in , lead foundation that supports overlooked and underfunded causes, including rare di…

Understanding AML vs. ALL: Navigating the complex field

Table of contents: Understanding AML vs. ALL: Navigating the complex fieldSimilarities and differences between AML and ALLCauses and risk factors: Und…

Suggested Reading - Childhood Leukemia Guide for Families, Friends and Caregivers, 5th ed.

This most complete parent guide provides accurate and understandable medical information about leukemia and the various treatment options, as well as …

Matthew

Our Matthew was first diagnosed with acute lymphoblastic leukemia (ALL) in August at the age of . He relapsed with ALL in December and underwent his…

Doug

In July , my defibrillator fired while I was at a diner. Upon testing at the hospital I found out I have acute promyelocytic leukemia (APL). Much to m…

211Astatine-CD123 Radioimmunotherapy for Cancer (Stem) Cell-Directed Treatment of Acute Leukemia

Because acute leukemias are very sensitive to radiation, radioisotopes are ideal payloads to arm antibodies against these , aggressive blood cancers. …

Giulia

A Leading Researcher Advancing Immunotherapy for Acute Myeloid LeukemiaIn Italy, Dr. Giulia Casorati is focused on adoptive cell immunotherapy to trea…

Glycotyping as a novel approach to study leukemia stem cell heterogeneity and function

Leukemia stem cells (LSCs) are highly heterogeneous populations and key contributors to AML progression. Here, I aim to employ heparan sulfate (HS) gl…

Let's Talk About Childhood Cancer: The Impact of Leukemia in Black Children

Identifying Mechanisms of Chemoresistance Induced by MECOM in Primary-Refractory Acute Myeloid Leukemia

Approximately % of Acute Myeloid Leukemia (AML) patients are “” () and fail to go into remission with intensive induction chemotherapy. These patients…